Literature DB >> 30449983

Autologous stem cell implantation with core decompression for avascular necrosis of the femoral head.

Nakul S Talathi1, Atul F Kamath1.   

Abstract

OBJECTIVE: Avascular necrosis (AVN) of the femoral head is a painful, progressive disease that can lead to limited mobility and early hip replacement. Autologous stem cell implantation into the necrotic lesion of the femoral head has been described, on the basis that patients with AVN have a reduced number of stem cells in the marrow. In this study, we aim to describe our technique for decompression of the hip with autologous implantation of stem cells for AVN of the femoral head, as well as retrospectively analyze our results.
METHODS: The records and imaging of patients with avascular necrosis of the femoral head treated by a single surgeon were retrospectively reviewed. All patients were treated with the combination of core decompression with autologous stem cell implantation from the iliac crest. Preoperatively, demographic information, stage of AVN per Association Research Circulation Osseous (ARCO) classification on magnetic resonance imaging and radiograph, and visual analogue pain scores (VAS) of the hip were recorded. Postoperatively, VAS were recorded and imaging was reviewed for progression of AVN or evidence of femoral head collapse. Statistical analysis was conducted comparing pre and postoperative VAS scores.
RESULTS: Overall, we treated 43 hips in 28 patients with autologous stem cell implantation, with an average follow up of 16 months. Patients ranged from ARCO Ia to ARCO IIc classification of AVN. The average pre-operative visual analogue scale (VAS) of pain was 7.8. Post operatively, the average VAS score decreased to 2.5 (p < 0.0001), with 78% of patients reporting at least a 50% decrease in pain. 40 of the 43 operatively treated hips showed no radiologic progression of the disease during the follow up period, while 3 of the 43 hips had evidence of femoral head collapse and needed subsequent total hip arthroplasty at an average of 17 months after the initial decompression.
CONCLUSION: Our findings indicate that hip compression with autologous stem cell implantation for AVN of the femoral head provides significant symptomatic relief and may be beneficial in arresting progression of disease.

Entities:  

Keywords:  Autologous bone marrow implantation; Avascular necrosis; Femoral head; Stem cells

Year:  2018        PMID: 30449983      PMCID: PMC6224688          DOI: 10.1016/j.jcot.2018.05.014

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  19 in total

1.  Treatment of osteonecrosis with autologous bone marrow grafting.

Authors:  Philippe Hernigou; Françoise Beaujean
Journal:  Clin Orthop Relat Res       Date:  2002-12       Impact factor: 4.176

2.  Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells.

Authors:  Dewei Zhao; Daping Cui; Benjie Wang; Fengde Tian; Lin Guo; Lei Yang; Baoyi Liu; Xiaobing Yu
Journal:  Bone       Date:  2011-11-07       Impact factor: 4.398

3.  The effect of core decompression on femoral head blood flow in steroid-induced avascular necrosis of the femoral head.

Authors:  G J Wang; S S Dughman; S I Reger; W G Stamp
Journal:  J Bone Joint Surg Am       Date:  1985-01       Impact factor: 5.284

Review 4.  Osteonecrosis of the femoral head.

Authors:  C J Lavernia; R J Sierra; F R Grieco
Journal:  J Am Acad Orthop Surg       Date:  1999 Jul-Aug       Impact factor: 3.020

Review 5.  Nontraumatic osteonecrosis of the femoral head: ten years later.

Authors:  Michael A Mont; Lynne C Jones; David S Hungerford
Journal:  J Bone Joint Surg Am       Date:  2006-05       Impact factor: 5.284

6.  Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head.

Authors:  Charles J Glueck; Richard A Freiberg; Ping Wang
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

7.  Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head.

Authors:  Valérie Gangji; Jean-Philippe Hauzeur; André Schoutens; Maurice Hinsenkamp; Thierry Appelboom; Dominique Egrise
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

8.  Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.

Authors:  Gildasio Cerqueira Daltro; Vitor Fortuna; Eliane Silva de Souza; Marcela Miranda Salles; Ana Claudia Carreira; Roberto Meyer; Songeli Menezes Freire; Radovan Borojevic
Journal:  Stem Cell Res Ther       Date:  2015-05-29       Impact factor: 6.832

Review 9.  Stem Cell Therapy for the Treatment of Hip Osteonecrosis: A 30-Year Review of Progress.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles-Henri Flouzat-Lachaniette
Journal:  Clin Orthop Surg       Date:  2016-02-13

10.  Aetiology and pathogenesis of bone marrow lesions and osteonecrosis of the knee.

Authors:  Maurilio Marcacci; Luca Andriolo; Elizaveta Kon; Nogah Shabshin; Giuseppe Filardo
Journal:  EFORT Open Rev       Date:  2017-03-13
View more
  1 in total

Review 1.  Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update.

Authors:  Michael A Mont; Hytham S Salem; Nicolas S Piuzzi; Stuart B Goodman; Lynne C Jones
Journal:  J Bone Joint Surg Am       Date:  2020-06-17       Impact factor: 6.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.